Vita Bella is a Nevada-based telehealth membership platform (Vita Bella Health, LLC) that offers compounded GLP-1 weight-loss medications alongside hormone therapy, peptides, sexual-wellness and anti-aging…
- TirzepatideFrom $159/mo
Assume we may earn a commission, at no cost to you. Partners we work with carry a small, fixed edge in where they are listed; the scores themselves are not adjusted.
- Semaglutide
- Not disclosed
- Tirzepatide
- From $159/mo (2.5 mg dose, plus a separate fee, compounded)
- Coverage
- 46 states
- Brand-name
- Compounded only
The scorecard
Vita Bella scored on our six published factors. See the methodology.
What we like
- Offers both compounded semaglutide (from $109/mo) and tirzepatide (from $159/mo) at member pricing, with supplies and a B-6 add-in included
- Clearly disclosed legal entity, Vita Bella Health, LLC (Nevada)
- Broad access: care published for 46 states plus Washington, D.C., and HSA cards are accepted
- Fully remote telehealth with video provider consults and quarterly provider check-ins included in the membership
- Medications dispensed by US FDA-inspected compounding pharmacies; ondansetron for nausea provided at no extra charge
The caveats
- Advertised $109-$159 medication prices require a separate $129/mo membership plus a one-time $99 consult, pushing true cost to ~$238-288/mo
- Three-month minimum commitment before it renews month-to-month; no refunds on medications and all sales are final
- Compounding pharmacy partners are not named anywhere on the site — a transparency gap
- Compounded semaglutide and tirzepatide are not FDA-approved; only the dispensing pharmacies are described as FDA-inspected
- Disputes are subject to binding arbitration with a class-action waiver, governed by Nevada law (Las Vegas jurisdiction)
The verdict
Best for: Adults wanting compounded semaglutide or tirzepatide inside a broader hormone and wellness membership.
Ranked #380 of 548 providers we have reviewed — for comparison, read our CoreAge Rx review, ranked #1. In the ranking it sits between Roboclinic at #379, 60/100 above and PauseRX at #381, 59/100 below, with the Nirwana Health write-up the next one down.
A grade C is a ranking, not an instruction to stop looking: the closest rivals to Vita Bella are scored on the identical rubric, so the comparison is like for like. This review sits inside a bigger picture: where tirzepatide is cheapest puts this review in context against every program we track. We have also compared it head to head: CoreAge Rx vs Vita Bella goes to CoreAge Rx, 94/100 to 60/100.
Compare Vita Bella
Compare with other providers
The closest reviews to Vita Bella by Verdict Score — the realistic shortlist if you are weighing this one up.
- #344Silhouette MD— Concierge-style GLP-1 telehealth offering compounded semaglutide and tirzepatide in both injectable and oral forms, with provider oversight and full-service support included on every plan.62/100
- #345TeleHealth Med— TeleHealth Med (TeleHealth Med, Inc.) is a Georgia-based telehealth weight-loss platform offering compounded semaglutide and tirzepatide in both injectable and sublingual forms through US-licensed…62/100
- #346Spry— Spry is a weight-loss and anti-aging telehealth platform pairing compounded semaglutide ($199/mo) and tirzepatide ($299/mo) with three longevity peptides — BPC-157, NAD+, and sermorelin ($249–$299/mo).62/100
- #347Luvo Health— Publishes an unusually complete price grid covering compounded injections, oral tablets and brand Ozempic and Zepbound, but charges you before any clinician has reviewed your intake.59/100
- #348VevaRX— Publishes a real 36-state list, then prices tirzepatide only by the quarter and carries another company's copy inside its own legal pages.61/100
- #349BeyondMD— Telehealth clinic offering competitively priced compounded semaglutide and tirzepatide.61/100
Pricing, states and verification reflect Vita Bella's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on Vita Bella's site. Not medical advice; see our disclosure.